The American Academy of Pediatrics is advising early and aggressive treatment of obesity in children, including resorting to risky medications and surgeries.
- In its updated guidance on childhood obesity, the American Academy of Pediatrics recommends weight loss drugs and surgery in children as young as 12 and 13
- The weight loss drug Wegovy causes gastrointestinal side effects, including nausea and vomiting, as well as concerns of pancreatitis, pancreatic cancer and retinopathy complications, including hemorrhage and blindness
- Subjecting children to surgery for weight loss is egregious, as it can lead to permanent complications and even death; the procedures may also involve removing a part of the body, which cannot be undone
- The AAP guidelines make no mention of controlling exposure to obesogens, ultraprocessed foods and other drivers of childhood obesity
- Part of the problem with the conventional model for treating childhood obesity is that children receive flawed nutritional guidance focused on reducing saturated fats and other whole foods, while promoting vegetable oils and low-fat diets
- By resorting to drugs and surgery, children may be saddled with a lifetime of related side effects, for a condition they could have likely reversed using natural lifestyle strategies